Approval · Notice of Compliance 13572 · 2012
SPIRIVA: Notice of Compliance 13572
Issued August 23, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13572
- Date
- August 23, 2012
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph toxicology section
- Therapeutic class
- Brochodilator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SPIRIVA | Not yet assigned | — |
Medicinal ingredients
- TIOTROPIUM BROMIDE MONOHYDRATE 18 MCG per CAP